Business Context and Reporting Period
Company: Alterity Therapeutics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: September 2020
Date Filed: September 9, 2020
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
This filing serves to incorporate by reference Appendix 4G and the 2020 Corporate Governance Statement into the company's Registration Statements on Form S-8 (File No. 333-228671) and Form F-3 (Files No. 333-220886 and 333-231417).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding corporate governance disclosures rather than a financial results report.
Material Changes
No material financial changes or operational updates are detailed in this specific filing text. The primary content is the submission of governance documents.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items. It focuses solely on the regulatory requirement to submit the 2020 Corporate Governance Statement.
Investor Verification Checklist
- Verify the contents of the referenced "Appendix 4G" and "2020 Corporate Governance Statement" to understand the specific governance updates.
- Confirm the status of the Registration Statements on Form S-8 and Form F-3 into which this filing is incorporated.
- Review subsequent filings for actual financial performance data, as this Form 6-K does not contain financial metrics.